Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leek, a vegetable belonging to the Allium genus (which also includes garlic and onion), is recognized for its nutritional and therapeutic significance. It contains principal bioactive compounds such as organosulfur compounds, flavonoids, and essential micronutrients. These phytochemicals exhibit potent antioxidant, anti-inflammatory, and anticancer activities. Leek-derived compounds, including extracellular vesicles (CL-EVs) from Chinese leek and extracts from Egyptian leek, are being investigated for their potential in preventing and managing chronic diseases like cancer, diabetes, and cardiovascular disorders, as well as ameliorating sarcopenia and depressive-like behaviors. Studies indicate that leek components modulate oxidative stress and inflammatory pathways, enhance metabolic and immune resilience, and influence mitochondrial biogenesis and autophagy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Leek.